Sheenu Chandwani

771 total citations
33 papers, 522 citations indexed

About

Sheenu Chandwani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Sheenu Chandwani has authored 33 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Economics and Econometrics. Recurrent topics in Sheenu Chandwani's work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Sheenu Chandwani is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Sheenu Chandwani collaborates with scholars based in United States, Italy and Germany. Sheenu Chandwani's co-authors include Kitaw Demissie, Thomas Burke, Elisa V. Bandera, Christine B. Ambrosone, Bruce G. Haffty, Sharad Goyal, Marie A. Chisholm‐Burns, Christopher Zacker, Francis L. Weng and Prethibha George and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of Surgical Oncology.

In The Last Decade

Sheenu Chandwani

33 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheenu Chandwani United States 13 251 124 111 84 81 33 522
Gurprataap Singh Sandhu United States 15 150 0.6× 125 1.0× 91 0.8× 10 0.1× 20 0.2× 24 514
Luz-Ma-Adriana Balderas-Peña Mexico 13 140 0.6× 39 0.3× 34 0.3× 27 0.3× 129 1.6× 41 630
Caterina Mele Italy 7 77 0.3× 38 0.3× 34 0.3× 45 0.5× 55 0.7× 20 386
Patrick R. Alba United States 11 96 0.4× 158 1.3× 27 0.2× 57 0.7× 51 0.6× 45 427
Hira Mian Canada 15 329 1.3× 52 0.4× 24 0.2× 22 0.3× 29 0.4× 109 668
Julie Doberne United States 11 47 0.2× 108 0.9× 82 0.7× 8 0.1× 68 0.8× 31 365
Franchette van den Berkmortel Netherlands 10 296 1.2× 174 1.4× 184 1.7× 125 1.5× 29 0.4× 22 587
Megan Coombes Canada 11 277 1.1× 144 1.2× 87 0.8× 16 0.2× 44 0.5× 16 624
Ainhoa Costas‐Chavarri United States 12 248 1.0× 68 0.5× 34 0.3× 85 1.0× 120 1.5× 21 490
Eric M. Maiese United States 13 109 0.4× 68 0.5× 8 0.1× 163 1.9× 60 0.7× 43 580

Countries citing papers authored by Sheenu Chandwani

Since Specialization
Citations

This map shows the geographic impact of Sheenu Chandwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheenu Chandwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheenu Chandwani more than expected).

Fields of papers citing papers by Sheenu Chandwani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheenu Chandwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheenu Chandwani. The network helps show where Sheenu Chandwani may publish in the future.

Co-authorship network of co-authors of Sheenu Chandwani

This figure shows the co-authorship network connecting the top 25 collaborators of Sheenu Chandwani. A scholar is included among the top collaborators of Sheenu Chandwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheenu Chandwani. Sheenu Chandwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castellanos, Emily, et al.. (2024). Raising the Bar for Real-World Data in Oncology: Approaches to Quality Across Multiple Dimensions. JCO Clinical Cancer Informatics. 8(8). e2300046–e2300046. 14 indexed citations
2.
Sillah, Arthur, et al.. (2024). Real-World Data Quality Framework for Oncology Time to Treatment Discontinuation Use Case: Implementation and Evaluation Study. JMIR Medical Informatics. 12. e47744–e47744. 1 indexed citations
3.
Chandwani, Sheenu, et al.. (2021). PCN37 An Oncology Real-World Data Assessment Framework for Outcomes Research. Value in Health. 24. S25–S25. 2 indexed citations
4.
Velcheti, Vamsidhar, Sheenu Chandwani, Xin Chen, Bilal Piperdi, & Thomas Burke. (2020). Pembrolizumab for Previously Treated, PD-L1–expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival. Clinical Lung Cancer. 21(5). e445–e455. 8 indexed citations
5.
Williams, Loretta A., Qiuling Shi, Seyedeh Dibaj, et al.. (2019). MA19.03 Differences in Symptom Burden Between Responsive and Progressive Disease in Advanced Non-Small Cell Lung Cancer (aNSCLC). Journal of Thoracic Oncology. 14(10). S327–S327. 1 indexed citations
6.
Chandwani, Sheenu, et al.. (2019). P2.16-41 Pembrolizumab for Previously Treated, PD-L1–Expressing Advanced NSCLC: Real-World Time on Treatment and Overall Survival. Journal of Thoracic Oncology. 14(10). S882–S882. 1 indexed citations
7.
Loong, Herbert H., Carlos King Ho Wong, Praveen Dhankhar, et al.. (2019). Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong. PharmacoEconomics - Open. 4(2). 235–247. 21 indexed citations
8.
Williams, Loretta A., Shiva Dibaj, Sheenu Chandwani, et al.. (2018). P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S907–S908. 1 indexed citations
9.
Huang, Mei‐Chih, et al.. (2018). PCN345 - HEALTH STATE UTILITIES IN METASTATIC NSCLC: A STUDY OF MULTIPLE IMMUNO-ONCOLOGY TRIALS. Value in Health. 21. S72–S73. 10 indexed citations
10.
Tan, Wan Ling, et al.. (2018). P1.16-07 Cost-Effectiveness of Pembrolizumab as 1st Line Treatment for Metastatic NSCLC Patients with High PD-L1 Expression in Singapore. Journal of Thoracic Oncology. 13(10). S630–S630. 2 indexed citations
11.
Chandwani, Sheenu, Seyedeh Dibaj, Emily Roarty, et al.. (2018). P3.01-91 Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape. Journal of Thoracic Oncology. 13(10). S901–S902. 1 indexed citations
12.
Nagarajan, Sairaman, et al.. (2017). Family Consumer Behaviors, Adolescent Prediabetes and Diabetes in the National Health and Nutrition Examination Survey (2007–2010). Journal of the American College of Nutrition. 36(7). 520–527. 8 indexed citations
13.
Llanos, Adana A. M., Sheenu Chandwani, Elisa V. Bandera, et al.. (2015). Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study. Cancer Causes & Control. 26(12). 1737–1750. 17 indexed citations
14.
George, Prethibha, Sheenu Chandwani, Molly Gabel, et al.. (2015). Diagnosis and Surgical Delays in African American and White Women with Early-Stage Breast Cancer. Journal of Women s Health. 24(3). 209–217. 71 indexed citations
15.
16.
Goyal, Sharad, Sheenu Chandwani, Bruce G. Haffty, & Kitaw Demissie. (2014). Effect of Travel Distance and Time to Radiotherapy on Likelihood of Receiving Mastectomy. Annals of Surgical Oncology. 22(4). 1095–1101. 59 indexed citations
17.
Gaur, Sunanda, et al.. (2014). Adverse Outcomes Among Asian Indian Singleton Births in New Jersey, 2008–2011. Journal of Immigrant and Minority Health. 17(4). 1138–1145. 5 indexed citations
18.
Chandwani, Sheenu, Prethibha George, Michelle Azu, et al.. (2014). Role of Preoperative Magnetic Resonance Imaging in the Surgical Management of Early-Stage Breast Cancer. Annals of Surgical Oncology. 21(11). 3473–3480. 23 indexed citations
19.
Maertens, Johan, Gerlinde Egerer, Wan Shik Shin, et al.. (2010). Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry. BMC Infectious Diseases. 10(1). 182–182. 37 indexed citations
20.
Winkler, M., Johann Pratschke, Uwe Schulz, et al.. (2010). Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study. Transplant Infectious Disease. 12(3). 230–237. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gurprataap Singh Sandhu Breakdown of academic impact, for papers by Luz-Ma-Adriana Balderas-Peña Breakdown of academic impact, for papers by Caterina Mele Breakdown of academic impact, for papers by Patrick R. Alba Breakdown of academic impact, for papers by Hira Mian Breakdown of academic impact, for papers by Julie Doberne Breakdown of academic impact, for papers by Franchette van den Berkmortel Breakdown of academic impact, for papers by Megan Coombes Breakdown of academic impact, for papers by Ainhoa Costas‐Chavarri Breakdown of academic impact, for papers by Eric M. Maiese
Rankless by CCL
2026